spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Teva Pharmaceuticals 

 HSMN NewsFeed - 30 Aug 2023
Alkermes Announces Settlement With Teva Related to VIVITROL(R) Patent Litigation
Biopharmaceuticals Litigation Licensing
 HSMN NewsFeed - 5 Dec 2022
NRx Pharmaceuticals Announces the Appointment of Carrie M. Carretta, PhD, APN-BC, AHN-BC, PMHNP, Senior Vice President of Clinical Development and Medical Affairs
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 9 Feb 2022
ARS Pharmaceuticals Expands Executive Leadership Team with Addition of Pharmaceutical Commercialization Veterans
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2021
Almirall announces Gianfranco Nazzi as new CEO
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 18 Nov 2020
Sutro Biopharma Announces the Appointment of Diana Landa as Vice President of Regulatory Affairs and Annie Chang as Head of Investor Relations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Nov 2019
STI Pharma Appoints Frank Mullery as President and Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Apr 2019
Neurelis Announces Completion of Senior Management Team Buildout to Support the Anticipated Commercial Launch of VALTOCO(TM)
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 3 Oct 2018
Rewind Therapeutics Appoints Leading Neuroscience Drug Developer Ian J. Reynolds as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Jun 2018
Orbis Biosciences(R) announces New Management Hires with addition of Chief Licensing Officer and Vice President of Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 1 Jun 2018
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Regenerative Medicine Personnel
 HSMN NewsFeed - 20 Apr 2018
Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 11 Apr 2018
InMed Announces Appointment of Joshua Blacher as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 23 Mar 2018
Lannett Strengthens, Augments Management Team
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 18 Jan 2018
Lannett Names Timothy C. Crew To Board Of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 21 Dec 2017
Lannett Appoints Timothy C. Crew As CEO
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 2 Nov 2017
BrainStorm Strengthens Executive Team: Appoints Eyal Rubin as Chief Financial Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 13 Sep 2017
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 19 Jul 2017
AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2017
Accera Appoints Dr. Judith Walker as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 27 Feb 2017
CTI BioPharma Announces Appointment of Hematology/Oncology Clinical Expert Adam Craig, M.D., Ph.D., as President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Oct 2016
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Sep 2016
Galmed Pharmaceuticals Announces the Appointment of Dr. Liat Hayardeny, Ph.D. MBA, as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Aug 2016
Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceutical
Biopharmaceuticals Distribution Acquisitions
 HSMN NewsFeed - 22 Jul 2016
VIVUS Announces Favorable Markman Ruling in Qsymia(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 13 Jun 2016
Lannett Receives FDA Approval For Neomycin Sulfate Tablets USP, 500 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 May 2016
BioLight Expands Its Product Portfolio With Eye Drops for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 3 May 2016
Patara Pharma Appoints Biotechnology Industry Leader John Schmid to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 May 2016
Endo Announces U.S. District Court Ruling Upholding OPANA(R) ER Intellectual Property
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 24 Feb 2016
Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE(R) (loxapine) inhalation powder
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 Feb 2016
Cocrystal Pharma Announces In-Licensing of CRISPR Cas Technologies for Hepatitis B Virus and Human Papilloma Virus
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Jan 2016
BioLight Reports Positive Second Clinical Study Results for its TeaRx(TM) Multi-Assay Test for Dry Eye Syndrome
Diagnostics Ophthalmology
 HSMN NewsFeed - 8 Dec 2015
Teva Pharmaceuticals and Eagle Pharmaceuticals Announce FDA Approval of BENDEKA(TM) (bendamustine hydrochloride) Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Nov 2015
Pfizer and Allergan to Combine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Nov 2015
Calimmune Expands Board of Directors, Names R. Scott Greer as Chairman
Biopharmaceuticals HIV/AIDS Personnel
 HSMN NewsFeed - 15 Oct 2015
Ovid Therapeutics Announces Appointment of Dr. Anna Kazanchyan to Senior Vice President, Business Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 Aug 2015
Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Apr 2015
Synta Announces Chen Schor Named President, Chief Executive Officer and Director
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Apr 2015
Akorn Announces Recent Executive Appointments
Biopharmaceuticals Generic Personnel
 HSMN NewsFeed - 1 Apr 2015
Corium Announces Appointment of Eric H. Bjerkholt to Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 2 Feb 2015
BioLight Reports Successful Clinical Study Results for Monitoring Bladder Cancer Recurrence with the CellDetect(R) Non-Invasive Test
Devices Diagnostics Oncology
 HSMN NewsFeed - 5 Dec 2014
Lannett Names Michael Bogda as President
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 24 Oct 2014
Elite Pharmaceuticals Announces New Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2014
Solstice Biologics Appoints Dr. Lou Tartaglia as President, Chief Executive Officer; John Borgeson Joins as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2014
Provectus Biopharmaceuticals Inc. Appoints Jacob M. Plotsker to Strategic Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2014
Dr. Edward Rudnic Appointed CEO of QRxPharma
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2014
Teva Settles Patent Litigation with Pfizer on Celebrex(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 2 Feb 2014
Forest Laboratories, Inc. Files Lawsuit Against Several Companies for Infringement of NAMENDA XR(R) Patents
Biopharmaceuticals Neurology Generics Litigation
 HSMN NewsFeed - 9 Jan 2014
Sorrento Therapeutics Welcomes William S. Marth as Chairman of the Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Dec 2013
Senesco Announces Letter of Intent to Merge with Fabrus
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 2 Dec 2013
Glenmark Announces Appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2013
AMAG Pharmaceuticals Appoints Robert F. Kaper, M.D. as Senior Vice President of Medical and Scientific Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Sep 2013
Alkermes Expands Senior Management Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Aug 2013
TetraLogic Pharmaceuticals Announces New Executives
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Jul 2013
BioDelivery Sciences Announces the Hiring of Adrian Hepner, M.D. as Vice President of Clinical Research & Regulatory Affairs
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 16 Jul 2013
BioSante Hires VP of New Business Development and Contract Manufacturing and Announces New Appointment to Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 8 May 2013
Teva and Alexza Announce Teva’s License to Market ADASUVE(R) in the U.S.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Mar 2013
United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex(R) (celecoxib capsules)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 28 Jan 2013
BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 28 Jan 2013
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 26 Oct 2012
Teva Receives Approval For SYNRIBO(TM) (Omacetaxine Mepesuccinate) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Oct 2012
Cubist Announces Management Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Oct 2012
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Sep 2012
Impax Laboratories Announces Settlement of Litigation Relating to CONCERTA(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Apr 2012
FDA Decides Teva is Sole First-to-File on Provigil(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 15 Feb 2012
BioSante Pharmaceuticals Announces FDA Approval for Bio-T-Gel™
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jan 2012
Intellipharmaceutics Appoints Vice President Business Development
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 27 Jan 2012
Spectrum Pharmaceuticals Strengthens Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jan 2012
Aerocrine appoints pulmonologist Paul Dorinsky, M.D., as medical director, North America
Devices Personnel
 HSMN NewsFeed - 5 Dec 2011
INSYS Therapeutics Announces Addition of VP of Marketing to Commercial Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 Oct 2011
The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva
Biopharmaceuticals Litigation
 HSMN NewsFeed - 22 Sep 2011
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Sep 2011
Impax Laboratories Appoints Carole Ben-Maimon, M.D. President of Global Pharmaceuticals
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 15 Aug 2011
Pfizer Wins Viagra Patent Trial
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 18 Jul 2011
BioSante Pharmaceuticals Announces Management Team Additions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Apr 2011
PhaseBio Pharmaceuticals, Inc. Announces the Appointment of Kathryn J. Gregory Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Apr 2011
Mersana Therapeutics Appoints Michael A. Metzger as EVP & COO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2011
Preliminary Injunction Ordered in POZEN Treximet Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 14 Feb 2011
BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data in Phase III Program
Biopharmaceuticals
 HSMN NewsFeed - 26 Jan 2011
APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection
Biopharmaceuticals Licensing Oncology
 HSMN NewsFeed - 8 Nov 2010
OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Sep 2010
Mersana Therapeutics Appoints Nicholas Bacopoulos President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2010
INTUNIV(TM) - Shire Files Suit Against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd.
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 14 Apr 2010
POZEN Enters into Settlement Agreement With Teva Regarding Paragraph IV Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 2 Mar 2010
Antares Pharma Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of Anturol for the Treatment of Overactive Bladder
Biopharmaceuticals Urology Drug Delivery
 HSMN NewsFeed - 16 Feb 2010
Aton Pharma Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2010
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jan 2010
Antares Pharma Expands Executive Team and Appoints Pavan Handa as Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2009
Trial Date Set for CUBICIN(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 2 Dec 2009
Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
Biopharmaceuticals Generics Litigation FDA
 HSMN NewsFeed - 19 Aug 2009
Merck Wins SINGULAIR(R) Patent Infringement Lawsuit
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 Aug 2009
Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective HDAC Inhibitors for Cancer and Rheumatoid Arthritis
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 29 Jul 2009
Mylan Announces Enhancements to Executive Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2009
Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin(R) (Human Growth Hormone)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 1 Jun 2009
BioLineRx Announces Positive Preliminary Results From the Phase I/II Trial of BL-1040, the First Injectable Device Addressing Pathological Cardiac Remodeling
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Apr 2009
Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Mar 2009
OSI Pharmaceuticals Files Patent Infringement Lawsuits Against Teva Pharmaceuticals USA and Mylan Pharmaceuticals
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 9 Mar 2009
Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 4 Feb 2009
Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2008
Capricorn Pharma and Teva Pharmaceuticals USA Enter Into Agreement
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 16 Jul 2008
Peptimmune Announces the Second Close of Series D Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Mar 2008
Barr Announces Reorganization of Senior Management, Business Functions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2008
First Patient Successfully Undergoes Breakthrough Treatment for Acute Myocardial Infarction Developed by BioLineRx
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Mar 2008
Pfizer Wins Challenge to Two Main U.S. Patents for Celebrex by Generic Manufacturer Teva
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 28 Feb 2008
Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel
Biopharmaceuticals Litigation
 HSMN NewsFeed - 29 Jan 2008
Wyeth Announces Launch of Own Generic Version of PROTONIX
Biopharmaceuticals Generics
 HSMN NewsFeed - 17 Jan 2008
Peptimmune Announces First Close of Series D Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jan 2008
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 27 Dec 2007
U.S. District Court Decision About Eisai's Legal Action Over Aricept ODT(R) ANDA Filing
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 24 Dec 2007
Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of PROTONIX Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 27 Aug 2007
BioLineRx In-Licenses Novel Drug for the Treatment of Acute Kidney Injury
Biopharmaceuticals Licensing
 HSMN NewsFeed - 22 Aug 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 9 Jul 2007
Barr Announces Approval of Generic Dostinex(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 Jun 2007
US Court Allows Teva to Resume US Sales of Its Generic Version of Lotrel
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 20 Mar 2007
Pfizer Wins Celebrex Patent Challenge by Generic Manufacturer Teva
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Feb 2007
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Jan 2007
Barr Launches Generic METAGLIP(TM) Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg
Biopharmaceuticals Generics Endocrinology
 HSMN NewsFeed - 16 Oct 2006
Purdue Pharma L.P. Announces Signing of Consent Judgment Ending OxyContin(R) Tablets Patent Lawsuit with Teva Pharmaceuticals
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 11 Oct 2006
Aero Pharm Acquires Baker Cummins(TM) Dermatology Products and U.S. Rights to Three Additional Dermatology Products from IVAX
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 27 Sep 2006
Gamida Cell Raises US$16 Million
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 29 Aug 2006
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with Teva Pharmaceuticals
Biopharmaceuticals Litigation
 HSMN NewsFeed - 31 May 2006
COPAXONE(R) Reduced Relapses and Stabilized Disability as Measured by Expanded Disability Status Scale, When Avonex(R) Failed
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 May 2006
Long-Term Copaxone(R) Study Showed 92% of Multiple Sclerosis Patients Were Still Walking Unaided After a Mean of 10 Years on Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Apr 2006
Teva Announces That Higher Dose of Copaxone(R) Showed Increased Efficacy in Multiple Sclerosis (MS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Mar 2006
AstraZeneca Commences Patent Infringement Litigation Against IVAX
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 3 Mar 2006
Shire Sues Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Feb 2006
Pfizer Petitions FDA to Recall Teva and Sandoz Generic Azithromycin Products to Correct Misbranding
Biopharmaceuticals FDA Generics Litigation
 HSMN NewsFeed - 18 Jan 2006
ADDERALL XR(R) - Paragraph IV Notice Update - Third Notice Letter From Teva Pharmaceuticals USA, Inc.
Biopharmaceuticals Generics
Return to NewsFeed  

 Additional items found! 46

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 46 additional stories matching:
Teva Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.